Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PharMedCon Europe AB
AB
Active
Org 5568824113
Karlbergsvägen 16, 113 27
Stockholm
Business and other management consultancy activities
·
NACE 7020
Est. 2012 · 14 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
PharMedCon Europe AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
0M
2022
2M
2023
1M
2024
1M
2025
EBITDA
SEK millions
3M
2M
1M
1M
0M
0M
2021
0M
0%
2022
2M
+200%
2023
0M
-100%
2024
0M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
2 037
800
640
Staff expenses
—
—
−289
−288
−452
EBITDA
−48
−25
1 587
431
123
Depreciation & amort.
−0
−0
—
—
—
EBIT
−48
−25
1 587
431
123
Net financials
14
—
12
23
2
Profit before tax
2
2
1 198
337
119
Tax
−0
−1
−248
−73
−28
Net profit
2
1
950
264
90
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 833
1 750
3 211
3 534
3 646
Equity
1 595
1 595
2 545
2 809
2 899
Long-term debt
0
0
—
—
—
Short-term debt
67
11
120
62
77
Total debt
67
11
120
62
77
Financial ratios
5-year trend
EBITDA margin
19.3%
This company
15.8%
Market median
+22% vs market
2021
2025
Equity ratio
79.5%
This company
38.2%
Market median
+108% vs market
2021
2025
Return on equity
3.1%
This company
18.4%
Market median
-83% vs market
2021
2025
Net profit margin
14.1%
This company
8.1%
Market median
+74% vs market
2021
2025
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
2021
2025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on PharMedCon Europe AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
